NRX Pharmaceuticals, Inc. (NRXP)
3.40
-0.27
(-7.36%)
USD |
NASDAQ |
Aug 26, 10:36
NRX Pharmaceuticals Debt to Equity Ratio : -7.329 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | -7.329 |
| March 31, 2026 | -0.0676 |
| December 31, 2025 | -0.0396 |
| September 30, 2025 | -0.4041 |
| June 30, 2025 | -0.2873 |
| March 31, 2025 | -0.3337 |
| December 31, 2024 | -0.2832 |
| September 30, 2024 | -0.3543 |
| June 30, 2024 | -0.4673 |
| March 31, 2024 | -0.4499 |
| December 31, 2023 | -0.7808 |
| September 30, 2023 | -1.670 |
| June 30, 2023 | -4.800 |
| March 31, 2023 | -42.92 |
| December 31, 2022 | 1.421 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 0.0158 |
| Date | Value |
|---|---|
| December 31, 2021 | 0.024 |
| September 30, 2021 | 0.059 |
| June 30, 2021 | -0.0173 |
| March 31, 2021 | 2.337 |
| December 31, 2020 | -0.0177 |
| September 30, 2020 | 0.7658 |
| June 30, 2020 | 0.6491 |
| March 31, 2020 | 0.5776 |
| December 31, 2019 | 0.0662 |
| September 30, 2019 | 0.0457 |
| June 30, 2019 | 0.0331 |
| March 31, 2019 | 0.0213 |
| December 31, 2018 | 0.0099 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 4.202 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Eli Lilly & Co. | 1.621 |
| Pfizer Inc. | 0.7418 |
| Oramed Pharmaceuticals, Inc. | 0.0023 |
| Yarrow Bioscience, Inc. | 0.00 |
| ANI Pharmaceuticals, Inc. | 1.022 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 34.16M |
| Total Liabilities (Quarterly) | 34.33M |
| Shareholders Equity (Quarterly) | -0.17M |
| Current Ratio | 0.8608 |
| Net Debt Paydown Yield | 0.81% |